Keywords
Atrial Fibrillation ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

193 Search results.

Eligibility Atrial Fibrillation NCT02506244

- 1/31/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
mHealth Screening to Prevent Strokes; ODM derived from: https://clinicaltrials.gov/show/NCT02506244

Eligibility Atrial Fibrillation NCT02498769

- 1/31/19 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT02498769

Eligibility Atrial Fibrillation NCT02497248

- 1/31/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Non-invasive Characterization of the Mechanisms of Atrial Fibrillation Maintenance; ODM derived from: https://clinicaltrials.gov/show/NCT02497248

Eligibility Atrial Fibrillation NCT02493075

- 1/31/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population; ODM derived from: https://clinicaltrials.gov/show/NCT02493075

Eligibility Atrial Fibrillation NCT02485925

- 1/31/19 - 1 form, 2 itemgroups, 34 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
SMART China, A Multi-center Clinical Registry Study; ODM derived from: https://clinicaltrials.gov/show/NCT02485925

Eligibility Atrial Fibrillation NCT02478294

- 1/30/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison Between Thoracoscopic Left Atrial Appendage Excision and Warfarin for the Secondary Prevention of Stroke in Patients With AF; ODM derived from: https://clinicaltrials.gov/show/NCT02478294

Eligibility Atrial Fibrillation NCT02463851

- 1/30/19 - 1 form, 2 itemgroups, 24 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT02463851

Eligibility Atrial Fibrillation NCT02461602

- 1/30/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02461602

Eligibility Atrial Fibrillation NCT02392754

- 1/30/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older; ODM derived from: https://clinicaltrials.gov/show/NCT02392754

Eligibility Atrial Fibrillation NCT02334852

- 1/30/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Registry of Atrial Fibrillation and Embolic Risk in Mexico; ODM derived from: https://clinicaltrials.gov/show/NCT02334852

Eligibility Atrial Fibrillation NCT02248753

- 1/30/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department; ODM derived from: https://clinicaltrials.gov/show/NCT02248753

Eligibility Atrial Fibrillation NCT02240667

- 1/30/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF); ODM derived from: https://clinicaltrials.gov/show/NCT02240667